Popular Articles
Burdock Root

CardioNet Announces Launch Of Clinical Indicator For Sleep Disorders
CardioNet, Inc. (NASDAQ:BEAT) announced the launch of SomNet ™, a new clinical indicator available in the Company"s existing Mobile Cardiac Outpatient Telemetry™ (MCOT™) system. Because many patients with cardiac disorders also suffer from common sleep disorders like sleep apnea, CardioNet believes that SomNet has the potential to identify patients with a high likelihood of such sleep disorders by measuring cyclic variation of heart rate (CVHR), a rhythm that is caused by repeated arousals from sleep due to such disorders. SomNet"s utility is based on data presented at the Heart Rhythm Society"s (HRS) 30th Annual Scientific Sessions in Boston.
generic viagra online
Journal Of Obstetrics And Gynecology Of India, Largest Circulation Medical Journal In India, Joins Springer Program
Springer, one of the leading publishers in the field of science, technology and medicine, has signed a cooperation agreement with the Federation of Obstetric and Gynaecological Societies of India (FOGSI) to publish The Journal of Obstetrics and Gynecology of India (JOGI).
News of the day
Pope, Obama To Hold Meeting After G-8 Summit
Pope Benedict XVI has agreed to meet with President Obama at the Vatican on July 10, according to White House spokesperson Robert Gibbs, the AP/Boston Globe reports. The Rev. Federico Lombardi, a Vatican spokesperson, on Wednesday said that the pope will hold an afternoon meeting with the president and first lady Michelle Obama after the conclusion of the Group of Eight industrialized nations summit meeting, a break with a Vatican tradition of holding midday meetings. The AP/Globe reports that the Vatican "clearly sought to accommodate" the president"s schedule, an indication that Benedict is interested in meeting with Obama despite his support for abortion rights and embryonic stem cell research.Some U.S. bishops have publicly attacked Obama"s support of abortion rights and embryonic stem cell research, which has fueled anticipation of a meeting between the president and the pope. Most recently, dozens of bishops denounced the University of Notre Dame"s decision to invite Obama to deliver its commencement address and receive an honorary degree. However, L"Osservatore Romano, the Vatican"s daily newspaper, said that Obama"s speech showed that he is looking for common ground on issues related to abortion. Obama also received a positive review from the newspaper after his first 100 days in office. An editorial in the paper said that Obama had not confirmed the "radical" direction on ethical questions he had discussed as a candidate (Simpson, AP/Boston Globe, 6/24).
Mental Health

Roche Launches Complete Detection Kit For Influenza A /H1N1 On LightCycler(R) System

Roche Applied Science announced the availability of a new detection kit for the Influenza A/H1N1 virus. The detection kit is offered for use in life science research. Roche currently is filing to get approval of the local health authorities worldwide for use of the kit in emergency situations. The kit runs on Roche÷´s LightCycler® 480 II, 2.0, and 1.5 systems. It was evaluated with virus positive sample materials and selectively identifies the new Influenza A H1N1 virus. Compared with other detection kits, it features a couple of advantages in regard to efficiency and handling. "The design of the new detection kits benefitted very much from information we got out of our manifold research cooperations. We are glad of our contribution in supplying fast and reliable tools for the detection of Influenza A/H1N1 to the research community," said Manfred Baier, Head of Roche Applied Science. Applied Science offers a variety of platforms that can be used to help identify the Influenza A H1N1 virus, including Nucleic Acid Purification, Real-Time PCR, Microarrays and Sequencing systems. The company is in close contact with various research institutions and test centers worldwide providing assistance in the detection and characterization of Influenza A H1N1 virus. Currently, there is no human vaccine on the market that protects against Influenza A H1N1 infection. Standard therapy for the disease includes treatment with antiviral drugs like Tamiflu or Relenza. For more information on Influenza A H1N1 please visit www.who.int. Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):